Remission in ankylosing spondylitis treated with anti-TNF-\u3b1 drugs: a national multicentre study

Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice

Arends, S.
Brouwer, Liesbeth
Efde, Monique
van der Veer, E.
Bootsma, H.
Wink, F.
Spoorenberg, A.

January 2017

Objective Randomised controlled trials and open-label extension studies have demonstrated the clinic...

Possibility of treatment modification in patients with ankylosing spondylitis achieved of partial remission on treatment with adalimumab: Real practice data

A. V. Petrov
Ya. O. Shevnina
A. S. Gaffarova
N. V. Matveeva

January 2021

Objective. To assess the duration of remission or inactive disease status in patients with achieved ...

Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study

Sieper, Joachim
Landewé, Robert
Magrey, Marina
Anderson, Jaclyn K.
Zhong, Sheng
Wang, Xin
Lertratanakul, Apinya

January 2019

Background This analysis assessed baseline predictors of remission in patients with non-radiographic...

Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study

Spadaro, Antonio
Lubrano, Ennio
Marchesoni, Antonio
D'Angelo, Salvatore
Ramonda, Roberta
Addimanda, Olga
Perrotta, Fabio Massimo
Olivieri, Ignazio
Punzi, Leonardo
SALVARANI, CARLO

January 2013

The primary objective of this retrospective study was to investigate the possibility of achieving pa...

Remission in ankylosing spondylitis treated with anti-TNF-α drugs: A national multicentre study

May 2017

none10noObjective: The primary objective of this retrospective study was to investigate the possibil...

Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

F.M. Perrotta
O. Addimanda
R. Ramonda
S. D’Angelo
E. Lubrano
A. Marchesoni
I. Olivieri
L. Punzi
C. Salvarani
A. Spadaro

November 2014

The objective of this study was to evaluate the predictive factors for achieving partial remission (...

Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study

Lubrano, Ennio
Perrotta, Fabio Massimo
Marchesoni, Antonio
D'Angelo, Salvatore
Ramonda, Roberta
Addimanda, Olga
Olivieri, Ignazio
Punzi, Leonardo
SALVARANI, CARLO

January 2015

Objective. To investigate the possibility of achieving partial remission (PR) in patients with non-r...

Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNF\u3b1 drugs

Perrotta, F. M
Addimanda, O
Ramonda, R
D'Angelo, S
Lubrano, E
Marchesoni, A
Olivieri, I
Punzi, L
Salvarani, Carlo
Spadaro, A.

January 2014

The objective of this study was to evaluate the predictive factors for achieving partial remission (...

Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-a drugs: An Italian multicenter study

May 2017

none9noObjective. To investigate the possibility of achieving partial remission (PR) in patients wit...

Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-\u3b1 drugs: an Italian multicenter study.

Lubrano, E
Perrotta, Fm
Marchesoni, A
D'Angelo, S
Ramonda, Roberta
Addimanda, O
Olivieri, I
Punzi, Leonardo
Salvarani, C.

January 2015

OBJECTIVE: To investigate the possibility of achieving partial remission (PR) in patients with nonra...

Achievement of remission endpoints with secukinumab over 3 years in active ankylosing spondylitis : pooled analysis of two phase 3 studies

Baraliakos, Xenofon
Van den Bosch, Filip
Machado, Pedro M.
Gensler, Lianne S.
Marzo-Ortega, Helena
Sherif, Bintu
Quebe-Fehling, Erhard
Porter, Brian
Gaillez, Corine
Deodhar, Atul

January 2021

Introduction Clinical remission in patients with ankylosing spondylitis (AS) has been determined usi...

Early Improvements in Disease Activity Indices Predict Long-Term Clinical Remission Suggested by the Treat-to-Target Strategy in Patients with Ankylosing Spondylitis Receiving TNF-α Inhibitor Treatment

Eon Jeong Nam
Won Kee Lee

September 2021

This study evaluated the possibility of clinical remission suggested by the treat-to-target strategy...

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study

Moreno Martínez-Losa, Mireia
Gratacós Masmitjà, Jordi.
Torrente-Segarra, V.
Sanmarti, R.
Morlà, R.
Pontes, C.
Llop, M.
Juanola, X.
Rodriguez-De-La-Serna, A.
Hernández Hernández, Vanesa
Riera, E.
Ortiz, V.
Clavaguera, T.
Reyner, P.
Sala, Miquel
Sellas, A.
Pitarch, C.
Reina, D.
Blanco, J.
Centelles, M.
Figuls, R.
Gelman, M.
Arasa, X.
Bonet, M.
Ciria, M.
Universitat Autònoma de Barcelona

Altres ajuts: This work is conducted under the umbrella of the Rheumatology Society of Catalonia and...

Efficacy of tumor necrosis factor inhibitors in patients with ankylosing spondylitis

Dulgeroglu Erdogdu, D.
Bal, A.
Karaahmet, O.
Erkoc, S.
Yalcin, T.
Cakci, A.

January 2014

Objectives: This study aims to investigate the efficacy of tumor necrosis factor-alpha blockers such...

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

Giardina, A.
FERRANTE, Angelo
CICCIA, Francesco
IMPASTATO, Rosalia
Miceli, M.
Principato, A.
TRIOLO, Giovanni

January 2010

The signs and symptoms of ankylosing spondylitis (AS) respond inadequately to nonsteroidal antiinfla...

Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice

Arends, S.
Brouwer, Liesbeth
Efde, Monique
van der Veer, E.
Bootsma, H.
Wink, F.
Spoorenberg, A.

January 2017

Objective Randomised controlled trials and open-label extension studies have demonstrated the clinic...

Possibility of treatment modification in patients with ankylosing spondylitis achieved of partial remission on treatment with adalimumab: Real practice data

A. V. Petrov
Ya. O. Shevnina
A. S. Gaffarova
N. V. Matveeva

January 2021

Objective. To assess the duration of remission or inactive disease status in patients with achieved ...

Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study

Sieper, Joachim
Landewé, Robert
Magrey, Marina
Anderson, Jaclyn K.
Zhong, Sheng
Wang, Xin
Lertratanakul, Apinya

January 2019

Background This analysis assessed baseline predictors of remission in patients with non-radiographic...

Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study

Spadaro, Antonio
Lubrano, Ennio
Marchesoni, Antonio
D'Angelo, Salvatore
Ramonda, Roberta
Addimanda, Olga
Perrotta, Fabio Massimo
Olivieri, Ignazio
Punzi, Leonardo
SALVARANI, CARLO

January 2013

The primary objective of this retrospective study was to investigate the possibility of achieving pa...

Remission in ankylosing spondylitis treated with anti-TNF-α drugs: A national multicentre study

May 2017

none10noObjective: The primary objective of this retrospective study was to investigate the possibil...

Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

F.M. Perrotta
O. Addimanda
R. Ramonda
S. D’Angelo
E. Lubrano
A. Marchesoni
I. Olivieri
L. Punzi
C. Salvarani
A. Spadaro

November 2014

The objective of this study was to evaluate the predictive factors for achieving partial remission (...

Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study

Lubrano, Ennio
Perrotta, Fabio Massimo
Marchesoni, Antonio
D'Angelo, Salvatore
Ramonda, Roberta
Addimanda, Olga
Olivieri, Ignazio
Punzi, Leonardo
SALVARANI, CARLO

January 2015

Objective. To investigate the possibility of achieving partial remission (PR) in patients with non-r...

Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNF\u3b1 drugs

Perrotta, F. M
Addimanda, O
Ramonda, R
D'Angelo, S
Lubrano, E
Marchesoni, A
Olivieri, I
Punzi, L
Salvarani, Carlo
Spadaro, A.

January 2014

The objective of this study was to evaluate the predictive factors for achieving partial remission (...

Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-a drugs: An Italian multicenter study

May 2017

none9noObjective. To investigate the possibility of achieving partial remission (PR) in patients wit...

Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-\u3b1 drugs: an Italian multicenter study.

Lubrano, E
Perrotta, Fm
Marchesoni, A
D'Angelo, S
Ramonda, Roberta
Addimanda, O
Olivieri, I
Punzi, Leonardo
Salvarani, C.

January 2015

OBJECTIVE: To investigate the possibility of achieving partial remission (PR) in patients with nonra...

Achievement of remission endpoints with secukinumab over 3 years in active ankylosing spondylitis : pooled analysis of two phase 3 studies

Baraliakos, Xenofon
Van den Bosch, Filip
Machado, Pedro M.
Gensler, Lianne S.
Marzo-Ortega, Helena
Sherif, Bintu
Quebe-Fehling, Erhard
Porter, Brian
Gaillez, Corine
Deodhar, Atul

January 2021

Introduction Clinical remission in patients with ankylosing spondylitis (AS) has been determined usi...

Early Improvements in Disease Activity Indices Predict Long-Term Clinical Remission Suggested by the Treat-to-Target Strategy in Patients with Ankylosing Spondylitis Receiving TNF-α Inhibitor Treatment

Eon Jeong Nam
Won Kee Lee

September 2021

This study evaluated the possibility of clinical remission suggested by the treat-to-target strategy...

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study

Moreno Martínez-Losa, Mireia
Gratacós Masmitjà, Jordi.
Torrente-Segarra, V.
Sanmarti, R.
Morlà, R.
Pontes, C.
Llop, M.
Juanola, X.
Rodriguez-De-La-Serna, A.
Hernández Hernández, Vanesa
Riera, E.
Ortiz, V.
Clavaguera, T.
Reyner, P.
Sala, Miquel
Sellas, A.
Pitarch, C.
Reina, D.
Blanco, J.
Centelles, M.
Figuls, R.
Gelman, M.
Arasa, X.
Bonet, M.
Ciria, M.
Universitat Autònoma de Barcelona

Altres ajuts: This work is conducted under the umbrella of the Rheumatology Society of Catalonia and...

Efficacy of tumor necrosis factor inhibitors in patients with ankylosing spondylitis

Dulgeroglu Erdogdu, D.
Bal, A.
Karaahmet, O.
Erkoc, S.
Yalcin, T.
Cakci, A.

January 2014

Objectives: This study aims to investigate the efficacy of tumor necrosis factor-alpha blockers such...

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

Giardina, A.
FERRANTE, Angelo
CICCIA, Francesco
IMPASTATO, Rosalia
Miceli, M.
Principato, A.
TRIOLO, Giovanni

January 2010

The signs and symptoms of ankylosing spondylitis (AS) respond inadequately to nonsteroidal antiinfla...

Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice

Arends, S.
Brouwer, Liesbeth
Efde, Monique
van der Veer, E.
Bootsma, H.
Wink, F.
Spoorenberg, A.

January 2017

Objective Randomised controlled trials and open-label extension studies have demonstrated the clinic...

Possibility of treatment modification in patients with ankylosing spondylitis achieved of partial remission on treatment with adalimumab: Real practice data

A. V. Petrov
Ya. O. Shevnina
A. S. Gaffarova
N. V. Matveeva

January 2021

Objective. To assess the duration of remission or inactive disease status in patients with achieved ...

Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study

Sieper, Joachim
Landewé, Robert
Magrey, Marina
Anderson, Jaclyn K.
Zhong, Sheng
Wang, Xin
Lertratanakul, Apinya

January 2019

Background This analysis assessed baseline predictors of remission in patients with non-radiographic...

Remission in ankylosing spondylitis treated with anti-TNF-\u3b1 drugs: a national multicentre study

Abstract

Extracted data

Remission in ankylosing spondylitis treated with anti-TNF-\u3b1 drugs: a national multicentre study

Abstract

Extracted data

Related items

Related items